Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07025044 · ClinicalTrials.gov registry record

Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections

A clinical trial of Urge Incontinence and Overactive Bladder (OAB), sponsored by Alexis Dieter.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT07025044 is a study of Urge Incontinence and Overactive Bladder (OAB) that is actively recruiting participants, run by Alexis Dieter. The registered enrollment target is 40 participants, below the 96-participant average among 7 other Urge Incontinence trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07025044, a study of Urge Incontinence and Overactive Bladder (OAB), is actively recruiting participants, sponsored by Alexis Dieter.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

Single-site prospective observational pilot feasibility study of women with overactive bladder/urge urinary incontinence undergoing onabotulinum toxin type A intradetrusor injections in order to achieve the following objectives: * Establish a record of successful collaboration with Dr. Ravel, an expert researcher in the female microbiome based at the University of Maryland * Demonstrate the investigators' ability to recruit subjects from the diverse population of postmenopausal women undergoing BTX for OAB within MedStar Health Urogynecology clinics * Collect, process and analyze urine specimens collected prior to and 4-weeks after BTX injection, and to compare the GU microbiome of self-collected versus clinic-collected samples * Assess response to BTX treatment and explore rates of and risk factors for urinary tract infection and incomplete voiding requiring catheterization within the first 4-weeks after BTX

Conditions Studied

Urge Incontinence Overactive Bladder (OAB)

Interventions

  • DRUG onabotulinum toxin type a

Study Locations (1)

District of Columbia

  • MedStar Urogynecology Clinic - Washington D.C.

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-03
Est. Completion 2026-06-01

Sponsor

Alexis Dieter

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07025044

The ClinicalTrials.gov registry entry for NCT07025044 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 7 other Urge Incontinence trials with a reported enrollment target (58% lower). The listed sponsor is Alexis Dieter, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Urge Incontinence appearing as the primary indexed condition, and to 1 intervention - of which onabotulinum toxin type a is the first listed.

NCT07025044 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT07025044 about?

NCT07025044 is a clinical study titled "Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections". Single-site prospective observational pilot feasibility study of women with overactive bladder/urge urinary incontinence undergoing onabotulinum toxin type A intradetrusor injections in order to achieve the following objectives: * Establish a record of successful collaboration with Dr. Ravel, an ex...

What is the current status of trial NCT07025044?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-09-03. Estimated completion is 2026-06-01.

What conditions does trial NCT07025044 study?

This clinical trial studies the following conditions: Urge Incontinence, Overactive Bladder (OAB).

What interventions are being tested in trial NCT07025044?

The interventions under investigation include: onabotulinum toxin type a (DRUG).

Who is sponsoring clinical trial NCT07025044?

This trial is sponsored by Alexis Dieter, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07025044 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urge Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urge Incontinence

All registered trials for this condition

Overactive Bladder (OAB)

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.